Acute respiratory infections (ARIs) are a leading cause of death in children under five globally. The seasonal trends and profiles of respiratory viruses vary by region and season. Due to limited information and the population’s vulnerability, we conducted the hospital-based surveillance of respiratory viruses in Eastern Uttar Pradesh. Throat and nasal swabs were collected from outpatients and inpatients in the Department of Paediatrics, Baba Raghav Das (BRD) Medical College, Gorakhpur, between May 2022 and April 2023. A total of 943 samples from children aged 1 to 60 months were tested using multiplex real-time PCR for respiratory viruses in cases of ARI and SARI. Out of 943 samples tested, the highest positivity was found for parainfluenza virus [105 (11.13%) PIV-1 (79), PIV-2 (18), PIV-4 (18)], followed by adenovirus [82 (8.7%), RSV-B, [68 (7.21%)], influenza-A [46(4.9%): H1N1 = 29, H3N2 = 14), SARS CoV-2 [28 (3%)], hMPV [13(1.4%), RSV-A [4 (0.42%), and influenza-B (Victoria lineage) 1 (0.10%). The maximum positivity of respiratory viruses was seen in children between 1 to 12 months. The wide variation in prevalence of these respiratory viruses was seen in different seasons. This study enhances understanding of the seasonal and clinical trends of respiratory virus circulation and co-infections in Eastern Uttar Pradesh. The findings highlight the importance of targeted interventions to reduce the burden of respiratory infections in this region.
Objective: To determine the Japanese encephalitis (JE)-associated long-term functional and neurological outcomes, the extent of reduced social participation and predictors of poor outcomes among paediatric JE survivors. Design: A retrospective cohort study. Setting: Laboratory-confirmed JE-positive paediatric cases (<16 years of age) hospitalised at the paediatric ward of Baba Raghav Das Medical College, Gorakhpur, India, between 1 January 2017 and 31 December 2017, were followed up after 6–12 months of hospital discharge. Participants: 126 patients were included in the study; median age was 7.5 years (range: 1.5–15 years), and 74 (58.73%) were male. Outcome measures: Functional outcome defined by Liverpool Outcome Score (LOS) dichotomised into poor (LOS=1–2) and good (LOS=3–5) outcome groups compared for demographic, clinical and biochemical parameters for prognostic factors of poor outcomes. Social participation of patients scaled on Child and Adolescent Scale of Participation score 2–5. Results: About 94 of 126 (74.6%) children developed neurological sequelae at different levels of severity. Age-expected social participation was compromised in 90 out of 118 children. In multivariate logistic regression analysis, a combination of parameters, JE unvaccinated status (OR: 61.03, 95% CI (14.10 to 264); p<0.001), low Glasgow Coma Score (GCS) at admission (≤8) (OR: 8.6, 95% CI (1.3 to 57.1); p=0.026), malnutrition (OR: 13.56, 95% CI (2.77 to 66.46); p=0.001) and requirement of endotracheal intubation (OR: 5.43, 95% CI (1.20 to 24.44); p=0.027) statistically significantly predicted the poor outcome with 77.8% sensitivity and 94.6% specificity. The goodness-of-fit test showed that the model fit well (Hosmer-Lemeshow goodness-of-fit test) ( χ2 =3.13, p=0.988), and area under the receiver operating characteristic curve was 0.950. Conclusion: This study estimates the burden of JE-presenting post-discharge deaths (15.4%) and disability (63.08%). Those who did not receive JE vaccine, were suffering from malnutrition, had GCS ≤8 at admission and required endotracheal intubation had poorer outcomes.
Introduction: Acute encephalitis syndrome (AES) poses a significant health challenge to children across India. Late arrival at tertiary care hospitals is a primary contributor to disease severity and poor outcomes. This study identifies the determinants of delayed health seeking and disease severity in AES cases. Methods: We interviewed the parents/guardians/caregivers of 242 patients with AES admitted at a tertiary care centre. Multivariable analyses identified factors for delayed health seeking, defined as >3 days spent at home after symptom onset; and disease severity on admission, defined as need for oxygen support. 131 patients were evaluated for long-term outcomes after 3 years using the Liverpool Outcome Score. Results: 90 (37.2%) patients had delayed health seeking and 202 (83.5%) had severe disease on admission. Lack of awareness about AES was a significant risk factor (OR 2.4, 95% CI 1.2 to 5.0, p=0.01) for delayed health seeking. Disease severity was associated with seeking treatment from uncertified medical practitioners (UMPs) (OR 7.3, 95% CI 2.7 to 19.8, p<0.01) and ≥2 days of time spent between the first healthcare provider and tertiary care admission (OR 3.0, 95% CI 1.3 to 7.3, p=0.01). At follow-up, disability was observed in 18.3% (n=24) of the patients. Conclusion: Delayed health seeking, treatment from UMPs and multiple healthcare consultations contributed to disease severity in patients with AES on admission at tertiary care health facilities.
10 September 2025 in Open Forum Infectious Diseases
Background: Neurologic complications associated with dengue infection have been increasingly recognized globally, particularly following detection of dengue virus in cerebrospinal fluid via polymerase chain reaction. Despite this, no prior study has assessed neurologic sequelae in patients with dengue-associated acute encephalitis syndrome (DEN-AES). This study aimed to evaluate the extent and domains of neurologic sequelae in pediatric DEN-AES cases. Methods: The study was conducted in 2023, including diagnosed DEN-AES cases (≤18 years) discharged between January 2018 and December 2019. DEN-AES was defined as acute fever onset with altered mental status (confusion, disorientation, coma, or inability to speak) and/or new seizures (excluding simple febrile seizures), as confirmed by NS1/IgM enzyme-linked immunosorbent assay and reverse transcription polymerase chain reaction tests for dengue. Long-term sequelae were assessed via home visits with a standardized disability assessment tool. Hospital records provided clinical, biochemical, and laboratory data for analysis. Results: Of 56 children (median age, 7.5 years [IQR, 5–10]; 53.6% male), neurologic sequelae of varying severity were observed in 22 (39.3%) cases. Severe disabilities were noted in 6 children, with 1 postdischarge death. Thirty-four children were fully recovered, scoring 5 on the Liverpool Outcome Score. Cognitive and behavioral impairments were the most common sequelae (37.5%), and 5 children required antiepileptic drugs for ongoing seizure management. Conclusions: Neurologic sequelae were identified in 39% of pediatric DEN-AES cases, underscoring the need for early diagnosis, continuous follow-up, and dedicated rehabilitation policies in dengue-endemic regions to support affected children.
A novel Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) led to Coronavirus Disease 2019 (COVID-19), which is a global health problem, that occurred in waves and resulted in high mortality globally. This is a single-centre retrospective study conducted in a Medical College's dedicated Covid hospital in India during the first wave (March-November 2020) and second wave (March-May 2021) of COVID-19 pandemic on 104 children below 18 years of age to compare the clinical characteristics and outcome of COVID-19 patients during the first and second waves. During first wave (n=57, 54.8%) majority of children (n=36, 63.16%) were between 5-18 years, but during the second wave (n=47, 62.09%), majority of children (n=29, 61.70%) were below 5 years. Neonates outnumbered during second wave (n=11, 23.4% vs n=1, 1.8%). Asymptomatic patients (n=24, 42.1%) were common during first wave, while severe-grade patients (n=19, 40.4%) were common during second wave. During both the waves, fever and respiratory distress were the common symptoms followed by cough. Respiratory distress (p=0.0003), CRP (p=.008), SPO2